Sign in

CIK 0002007919

  • Emerging growth company

Inhibrx Biosciences, Inc.

Sign in to watch
Ticker
INBX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
990613523
Phone
+1 858-795-4220
Business address
11025 N. TORREY PINES ROAD, SUITE 140, LA JOLLA, CA, 92037
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 3 Insider Initial Statement of Ownership
  7. 4 Gift Director gave 90,000 shares (gift)
  8. 4 Gift Director gave 500,000 shares (gift)
  9. 4 Gift Director gave 52,000 shares (gift)
  10. 4 Open-market buy Director bought 107,186 shares at an average $14.21 ($1,523,620)
  11. 4 Open-market buy Director bought 6,667 shares at $15.00 ($100,005)
  12. 4 Open-market buy Chief Executive Officer bought 40,000 shares at an average $15.73 ($629,117)
  13. 4 Open-market buy Director bought 6,636 shares at an average $15.07 ($99,992)
  14. 4 Open-market buy Chief Executive Officer bought 44,000 shares at an average $15.25 ($671,150)
  15. 4 Open-market buy Chief Executive Officer bought 40,000 shares at an average $14.92 ($596,763)
  16. 4 Open-market buy Director bought 7,140 shares at $14.00 ($99,960)
  17. 4 Open-market buy Director bought 10,000 shares at $13.98 ($139,800)
  18. 4 Open-market buy Director bought 75,000 shares at an average $13.83 ($1,037,328)
  19. 4 Open-market buy Chief Executive Officer bought 40,000 shares at an average $12.96 ($518,282)
  20. 4 Gift Director gave 89,050 shares (gift)

Page 2 of 3 · 59 filings